Market Place
Sourcing Support
Tillotts and TVM Capital form Mage Biologics to develop oral antibody therapy
21 Jul 2023 //
INDIAN PHARMA POST
Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada
07 Apr 2023 //
ECONOMIC TIMES
Tillotts Standardizes on Veeva Commercial Cloud Applications
28 Sep 2022 //
PRNEWSWIRE
Tillotts Pharma: DIFICLIRTM is recommended for C. difficile infection
07 Dec 2021 //
BUSINESSWIRE
Tillotts introduces Opticore for colonic targeting active molecules
21 Nov 2016 //
PHARMABIZ
Recipharm, Tillotts Pharma enter long term supply agreement
01 Sep 2016 //
PHARMABIZ
Perrigo nabs US rights to AZ Crohn’s drug
08 Dec 2015 //
RSC
AstraZeneca sells U.S. drug rights to Perrigo for $380 mln
24 Nov 2015 //
REUTERS
AstraZeneca divests off gastro drug for $215 mn
14 Jul 2015 //
BIOSPECTRUM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.